Detalhe da pesquisa
1.
Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact.
Blood
; 133(11): 1205-1216, 2019 03 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-30602617
2.
Real-life experience with the combination of polatuzumab vedotin, rituximab, and bendamustine in aggressive B-cell lymphomas.
Hematol Oncol
; 39(3): 336-348, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33583077
3.
Another window into tumor microenvironment: a case of Β-cell rich folliculotropic mycosis fungoides responding to rituximab.
Australas J Dermatol
; 61(2): e226-e228, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-31944261
4.
Validation of the simplified International Prognostic Score3 in a Hellenic cohort of patients with advanced-stage Hodgkin-lymphoma.
Br J Haematol
; 190(6): e335-e339, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32602960
5.
Serum ferritin levels in previously untreated classical Hodgkin lymphoma: correlations and prognostic significance.
Leuk Lymphoma
; 63(4): 799-812, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35188040
6.
Complete eradication of chronic lymphocytic leukemia with unusual skin involvement of high mitotic index after time-limited venetoclax/obinutuzumab treatment.
Clin Case Rep
; 9(7): e04514, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34322260
7.
Allogeneic Stem Cell Transplantation with a Novel Reduced Intensity Conditioning Regimen for the Treatment of Patients with Primary Cutaneous T-cell Lymphomas.
Clin Hematol Int
; 3(2): 72-76, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34595469
8.
Safety and efficacy analysis of long-term follow up real-world data with ibrutinib monotherapy in 58 patients with CLL treated in a single-center in Greece.
Leuk Lymphoma
; 60(12): 2939-2945, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31184241
9.
New insights into granulomatous mycosis fungoides (GMF): a single-center experience.
Eur J Cancer
; 156 Suppl 1: S69-S70, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34649669
10.
5-Azacytidine in the Treatment of Intermediate-2 and High-risk Myelodysplastic Syndromes and Acute Myeloid Leukemia. A Five-year Experience with 44 Consecutive Patients.
Anticancer Res
; 35(9): 5141-7, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26254419
11.
PARP1-driven apoptosis in chronic lymphocytic leukemia.
Biomed Res Int
; 2014: 106713, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25161998
12.
An adult patient with systemic mastocytosis and B-acute lymphoblastic leukemia.
Case Rep Med
; 2014: 526129, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25431599
13.
Gastric involvement in patients with primary mediastinal large B-cell lymphoma.
Anticancer Res
; 34(11): 6717-23, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25368280
14.
Survivin messenger RNA levels in Epstein-Barr virus-positive patients with leukemic low-grade B-cell lymphomas expressing the latent membrane protein 1: evidence of apoptotic function?
Clin Lymphoma Myeloma Leuk
; 14(1): 56-60, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24262330
15.
Evidence for regulation of oxidative stress by latent membrane protein 1 oncoprotein in patients with low-grade leukemic B cell lymphoma with latent Epstein-Barr virus infection.
Leuk Lymphoma
; 55(8): 1904-9, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24261679
16.
Cessation of tyrosine kinase inhibitors in patients with chronic-phase chronic myelogenous leukemia following durable complete molecular response: a single center facing the dilemma.
Anticancer Res
; 33(8): 3509-14, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23898127
17.
Rituximab in the treatment of EBV-positive low grade B-cell lymphoma.
Anticancer Res
; 33(12): 5693-8, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24324119